Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
12:28pm, Wednesday, 29'th Mar 2023
J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
11:05am, Wednesday, 29'th Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
Better Growth Stock: AbbVie vs. Pfizer
07:30am, Wednesday, 29'th Mar 2023
AbbVie might not grow much in 2023 and 2024. Pfizer will see tens of billions of its sales evaporate soon.
2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever
09:53am, Tuesday, 28'th Mar 2023
Pfizer is in the process of pumping out new products to help replace its coronavirus lineup. Abbott has a diversified business centered around its highly successful medical devices unit.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:43am, Monday, 27'th Mar 2023
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
2 Rock Solid Dividend Stocks to Buy on the Dip
09:56am, Monday, 27'th Mar 2023
Pfizer has some fierce headwinds coming up, but they won't last forever. NextEra Energy is going to keep adding to its earnings regardless of its share price.
BioNTech Is Ripe For A Rebound In 2023
09:44am, Monday, 27'th Mar 2023
BioNTech (NASDAQ: BNTX) got a substantial boost from the pandemic and its mRNA vaccine, developed with Pfizer (NYSE: PFE). The stock has seen a substantial correction since then due to slowing COVID s
3 Low P/E Stocks That Are Bound to Rebound This Year
09:24am, Monday, 27'th Mar 2023
Be it growth or blue-chip stocks, a key success factor is to invest in undervalued names. This might sound simple, but the rule is often ignored.
Pfizer signs agreement with China on improving health coverage in the country
10:47pm, Sunday, 26'th Mar 2023
U.S. pharma giant Pfizer has signed an agreement with China to cooperate on improving the country's health coverage, according to the company.
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
11:11am, Sunday, 26'th Mar 2023
Veeva is a major (and growing) cloud-based software provider to the life sciences industry. Booking Holdings is close to booking a billion room nights annually via its many services.
10 Dividend Growth Stocks - March 2023
09:00am, Sunday, 26'th Mar 2023
This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration. To rank stocks, I sort them in descending order by quality s
This Cancer Drug Candidate Could Be a Hit for Pfizer
10:15am, Saturday, 25'th Mar 2023
Elranatamab showed itself to be an effective therapy for multiple myeloma patients. The drug candidate has great potential in a market estimated at some $20 billion.
Can This New Drug Boost Pfizer's Stock?
09:45am, Saturday, 25'th Mar 2023
Zavzpret is a nasal spray for treating acute migraine in adults. It could net the drug giant more than $700 million in annual sales.
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says
10:03am, Friday, 24'th Mar 2023
People who took Pfizer's antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn't, the study said.
